» Articles » PMID: 35883470

Optimized AAV Vectors for TMC1 Gene Therapy in a Humanized Mouse Model of DFNB7/11

Overview
Journal Biomolecules
Publisher MDPI
Date 2022 Jul 27
PMID 35883470
Authors
Affiliations
Soon will be listed here.
Abstract

Gene therapy for genetic hearing loss is an emerging therapeutic modality for hearing restoration. However, the approach has not yet been translated into clinical application. To further develop inner-ear gene therapy, we engineered a novel mouse model bearing a human mutation in the transmembrane channel-1 gene () and characterized the auditory phenotype of the mice. TMC1 forms the mechanosensory transduction channel in mice and humans and is necessary for auditory function. We found that mice harboring the equivalent of the human p.N199I mutation (p.N193I) had profound congenital hearing loss due to loss of hair cell sensory transduction. Next, we optimized and screened viral payloads packaged into AAV9-PHP.B capsids. The vectors were injected into the inner ears of mice and the new humanized -p.N193I mouse model. Auditory brainstem responses (ABRs), distortion product otoacoustic emissions (DPOAEs), cell survival, and biodistribution were evaluated in the injected mice. We found broad-spectrum, durable recovery of auditory function in -p.N193I mice injected with AAV9-PHP.B-. ABR and DPOAE thresholds were equivalent to those of wild-type mice across the entire frequency range. Biodistribution analysis revealed viral DNA/RNA in the contralateral ear, brain, and liver but no overt toxicity. We conclude that the AAV9-PHP.B- construct may be suitable for further development as a gene therapy reagent for treatment of humans with genetic hearing loss due to recessive mutations.

Citing Articles

The Diverse Functions of the Calcium- and Integrin-Binding Protein Family.

Wang X, Yi Z, Shi M, Sun Y Int J Mol Sci. 2025; 26(5).

PMID: 40076845 PMC: 11900603. DOI: 10.3390/ijms26052223.


Inner Ear Gene Therapy: An Overview from Bench to Bedside.

Gadenstaetter A, Krumpoeck P, Landegger L Mol Diagn Ther. 2024; 29(2):161-181.

PMID: 39625555 PMC: 11861411. DOI: 10.1007/s40291-024-00759-1.


Sensory transduction in auditory hair cells-PIEZOs can't touch this.

Holt J, Fettiplace R, Muller U J Gen Physiol. 2024; 156(6).

PMID: 38727631 PMC: 11090049. DOI: 10.1085/jgp.202413585.


TMC function, dysfunction, and restoration in mouse vestibular organs.

Ratzan E, Lee J, Madison M, Zhu H, Zhou W, Geleoc G Front Neurol. 2024; 15:1356614.

PMID: 38638308 PMC: 11024474. DOI: 10.3389/fneur.2024.1356614.


Autosomal Recessive Non-Syndromic Deafness: Is AAV Gene Therapy a Real Chance?.

Brotto D, Greggio M, de Filippis C, Trevisi P Audiol Res. 2024; 14(2):239-253.

PMID: 38525683 PMC: 10961695. DOI: 10.3390/audiolres14020022.


References
1.
Pan B, Geleoc G, Asai Y, Horwitz G, Kurima K, Ishikawa K . TMC1 and TMC2 are components of the mechanotransduction channel in hair cells of the mammalian inner ear. Neuron. 2013; 79(3):504-15. PMC: 3827726. DOI: 10.1016/j.neuron.2013.06.019. View

2.
Kurima K, Peters L, Yang Y, Riazuddin S, Ahmed Z, Naz S . Dominant and recessive deafness caused by mutations of a novel gene, TMC1, required for cochlear hair-cell function. Nat Genet. 2002; 30(3):277-84. DOI: 10.1038/ng842. View

3.
Kawashima Y, Geleoc G, Kurima K, Labay V, Lelli A, Asai Y . Mechanotransduction in mouse inner ear hair cells requires transmembrane channel-like genes. J Clin Invest. 2011; 121(12):4796-809. PMC: 3223072. DOI: 10.1172/JCI60405. View

4.
Meyers J, MacDonald R, Duggan A, Lenzi D, Standaert D, Corwin J . Lighting up the senses: FM1-43 loading of sensory cells through nonselective ion channels. J Neurosci. 2003; 23(10):4054-65. PMC: 6741082. View

5.
Lee J, Nist-Lund C, Solanes P, Goldberg H, Wu J, Pan B . Efficient viral transduction in mouse inner ear hair cells with utricle injection and AAV9-PHP.B. Hear Res. 2020; 394:107882. DOI: 10.1016/j.heares.2020.107882. View